Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eyenovia Inc
(NQ:
EYEN
)
0.7113
+0.0213 (+3.09%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eyenovia Inc
< Previous
1
2
3
4
Next >
Glancy Prongay & Murray LLP Announces Investigation of Eyenovia, Inc. (EYEN)
June 15, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
Eyenovia Expands Its US Manufacturing Capabilities
June 06, 2023
Via
ACCESSWIRE
Eyenovia, Inc. (NASDAQ:EYEN) Investor Notice: Investigation over Possible Securities Laws Violations
May 24, 2023
San Diego, CA -- (SBWIRE) -- 05/24/2023 -- An investigation was announced for investors of Eyenovia, Inc. (NASDAQ:EYEN) shares over potential securities laws violations by Eyenovia, Inc.
Via
SBWire
Recap: Eyenovia Q1 Earnings
May 11, 2023
Via
Benzinga
A Preview Of Eyenovia's Earnings
May 10, 2023
Via
Benzinga
Eyenovia Shares Dip Despite FDA Approving Its First Product
May 08, 2023
The FDA approved Eyenovia Inc's (NASDAQ: EYEN) Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for inducing mydriasis for diagnostic procedures and in conditions where...
Via
Benzinga
Glancy Prongay & Murray LLP Announces Investigation of Eyenovia, Inc. (EYEN)
May 08, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
Eyenovia Inc. (NASDAQ: EYEN) Records 52-Week High Tuesday Morning
April 04, 2023
Via
Investor Brand Network
Preview: Eyenovia's Earnings
March 29, 2023
Via
Benzinga
HC Wainwright Initiates This Eye-Focused Stock With Almost 400% Upside
October 05, 2022
Via
Benzinga
Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter
April 17, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Eyenovia Showcases Microdose Array Print (MAP™) Technology at CES 2023 in Las Vegas
January 31, 2023
In the Digital Health and Startups category at the 2023 Consumer Electronics Show (CES), Eyenovia showcased its Microdose Array Print (MAP™) Technology, the first significant advancement in ocular drug...
Via
Newswire.com
Eyenovia's Optejet Shows Lower Proinflammatory Cytokines Levels, Chemokines Than Standard Drops
January 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 12, 2023
Via
Benzinga
Eyenovia Aims to Revolutionize Ophthalmology Devices With Microdose Array Print (MAP) Technology
December 22, 2022
The Microdose Array Print (MAP) Technology has shown potential in clinical trials, providing the possibility of more accurate ocular drug delivery than traditional eye droppers
Via
Newswire.com
Recap: Eyenovia Q2 Earnings
August 10, 2022
Eyenovia (NASDAQ:EYEN) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Outlook For Eyenovia
November 09, 2022
Eyenovia (NASDAQ:EYEN) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that Eyenovia will...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 20, 2022
Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value of their outstanding shares is at $96.2 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
October 17, 2022
Good morning, investor! It's time to start off the trading week with a breakdown of the biggest pre-market stock movers on Monday!
Via
InvestorPlace
Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket
October 17, 2022
Gainers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022
October 05, 2022
Upgrades
Via
Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
September 09, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...
Via
Benzinga
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday
September 02, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 01, 2022
Via
Benzinga
Eyenovia's Novel Optejet® Dispenser Puts People's Eyes First
August 30, 2022
While traditional eye drop bottles require hand-eye coordination and deliver four to five times more medication than the human eye can hold, the Optejet® dispenser's human-centric design administers an...
Via
Newswire.com
Stocks That Hit 52-Week Lows On Thursday
August 25, 2022
On Thursday, 63 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 24, 2022
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares moved upwards by 20.1% to $1.79 during Wednesday's after-market session. The market value of their outstanding shares is at $31.6 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 10, 2022
Via
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Eyenovia's Earnings Outlook
August 09, 2022
Eyenovia (NASDAQ:EYEN) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement. Analysts estimate that Eyenovia will...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.